SPARTACUS BIOMED

Who are we

Spartacus-Biomed: Redefining Rapid Diagnostics and Precision Medicine

Spartacus-Biomed (SB) is a French ISO 13485-certified biotechnology company, awarded multiple innovation grants from the French State and the Occitanie Region. The company specializes in advanced diagnostic and therapeutic solutions for complex medical conditions in cardiology, oncology, infectious diseases and personalized medicine.

With 11 patents filed, including three internationally granted, Spartacus-Biomed has built a robust intellectual property portfolio supporting a new generation of rapid and connected diagnostic tools. Its latest achievement, the FILDARIA Heart Failure Rapid Test Device, uses a patented Heart Failure biomarker to deliver accurate results in just 10 minutes from a single drop of blood, bringing laboratory precision directly to the point of care. Building on this expertise, Spartacus-Biomed has also developed a connected, smartphone-sized monitoring device that enables continuous remote follow-up of heart failure patients, ensuring better disease management beyond the hospital setting.

The company values collaboration and clinical excellence, working closely with universities, research institutes, and healthcare providers to accelerate the translation of scientific innovation into practical medical solutions. Backed by a multidisciplinary team of cardiologists, scientists, and engineers, and supported by automated mass-production capabilities, Spartacus-Biomed operates to the highest ethical and regulatory standards.

Driven by innovation and a strong commitment to patient care, Spartacus-Biomed’s mission is to transform the future of diagnostics, monitoring, and precision healthcare worldwide.